GLORY HEALTH IND. HD-001 (84R) - Net Assets

Latest as of December 2024: €12.37 Billion EUR ≈ $14.46 Billion USD

Based on the latest financial reports, GLORY HEALTH IND. HD-001 (84R) has net assets worth €12.37 Billion EUR (≈ $14.46 Billion USD) as of December 2024. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€57.20 Billion ≈ $66.88 Billion USD) and total liabilities (€44.83 Billion ≈ $52.42 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read how much debt does GLORY HEALTH IND. HD-001 carry for a breakdown of total debt and financial obligations.

Key Net Assets Metrics

Metric Value
Current Net Assets €12.37 Billion
% of Total Assets 21.62%
Annual Growth Rate -7.11%
5-Year Change N/A
10-Year Change N/A
Growth Volatility 2.51

GLORY HEALTH IND. HD-001 - Net Assets Trend (2021–2024)

This chart illustrates how GLORY HEALTH IND. HD-001's net assets have evolved over time, based on quarterly financial data. Also explore balance sheet size of GLORY HEALTH IND. HD-001 for the complete picture of this company's asset base.

Annual Net Assets for GLORY HEALTH IND. HD-001 (2021–2024)

The table below shows the annual net assets of GLORY HEALTH IND. HD-001 from 2021 to 2024. For live valuation and market cap data, see 84R market cap.

Year Net Assets Change
2024-12-31 €12.37 Billion
≈ $14.46 Billion
-10.27%
2023-12-31 €13.79 Billion
≈ $16.12 Billion
-4.13%
2022-12-31 €14.38 Billion
≈ $16.81 Billion
-6.84%
2021-12-31 €15.43 Billion
≈ $18.05 Billion
--

Equity Component Analysis

This analysis shows how different components contribute to GLORY HEALTH IND. HD-001's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 808337600000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings €8.08 Billion 81.41%
Other Components €1.85 Billion 18.59%
Total Equity €9.93 Billion 100.00%

GLORY HEALTH IND. HD-001 Competitors by Market Cap

The table below lists competitors of GLORY HEALTH IND. HD-001 ranked by their market capitalization.

Company Market Cap
Ekso Bionics Holdings Inc
NASDAQ:EKSO
$28.58 Million
Dyadic International Inc
NASDAQ:DYAI
$28.59 Million
Workhorse Group Inc
NASDAQ:WKHS
$28.60 Million
DIAMINES AND CHEMICALS ORD (BSE)
NSE:DIAMINESQ
$28.60 Million
Prestar Resources Bhd
KLSE:9873
$28.57 Million
SFD SA ZY -10
F:7PQ
$28.55 Million
Geekay Wires Limited
NSE:GEEKAYWIRE
$28.55 Million
Ponni Sugars (Erode) Limited
NSE:PONNIERODE
$28.55 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in GLORY HEALTH IND. HD-001's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 11,169,120,000 to 9,928,691,000, a change of -1,240,429,000 (-11.1%).
  • Net loss of 1,240,429,000 reduced equity.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income €-1.24 Billion -12.49%
Total Change €- -11.11%

Book Value vs Market Value Analysis

This analysis compares GLORY HEALTH IND. HD-001's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.00x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2021-12-31 €2.86 €0.01 x
2022-12-31 €2.64 €0.01 x
2023-12-31 €2.51 €0.01 x
2024-12-31 €2.23 €0.01 x

Capital Efficiency Dashboard

This dashboard shows how efficiently GLORY HEALTH IND. HD-001 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -12.49%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -45.85%
  • • Asset Turnover: 0.05x
  • • Equity Multiplier: 5.76x
  • Recent ROE (-12.49%) is below the historical average (-5.88%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2021 1.80% 2.31% 0.16x 4.81x €-1.04 Billion
2022 -7.78% -23.38% 0.07x 4.89x €-2.09 Billion
2023 -5.05% -22.50% 0.04x 5.05x €-1.68 Billion
2024 -12.49% -45.85% 0.05x 5.76x €-2.23 Billion

Industry Comparison

This section compares GLORY HEALTH IND. HD-001's net assets metrics with peer companies in the Real Estate - Development industry.

Industry Context

  • Industry: Real Estate - Development
  • Average net assets among peers: $26,870,789,207
  • Average return on equity (ROE) among peers: -24.55%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
GLORY HEALTH IND. HD-001 (84R) €12.37 Billion 1.80% 3.62x $28.58 Million
RONSHINE CH.HLD.HD-00001 (1R7) $22.79 Billion -25.98% 5.46x $19.02 Million
Pruksa Holding Public Company Limited (2PR3) $43.47 Billion 1.05% 0.52x $181.69 Million
Zhong An Group Limited (35Z) $9.06 Billion 6.04% 1.49x $39.53 Million
Sino-Ocean Group Holding Limited (3SD) $76.45 Billion 3.57% 2.68x $158.20 Million
HUIJING HLDG.CO.LTD HD-01 (3XU) $1.32 Billion -186.00% 8.26x $5.25 Million
ZHONGLIANG HLDG HD-01 (3ZH) $19.38 Billion -12.52% 5.87x $8.69 Million
China Aoyuan Group Limited (47C) $11.58 Billion 7.02% 3.22x $27.52 Million
LOGAN GROUP HD -10 (5LP) $32.73 Billion -27.29% 6.59x $761.17 Million
CIFI Holdings (Group) Co. Ltd (6CI) $51.92 Billion -13.15% 3.93x $87.98 Million
NYESA VALOS CO.EO 001 (7NY0) $19.21 Million 1.72% 1.61x $21.43 Million

About GLORY HEALTH IND. HD-001

F:84R Germany Real Estate - Development
Market Cap
$28.58 Million
€24.44 Million EUR
Market Cap Rank
#23856 Global
#2076 in Germany
Share Price
€0.01
Change (1 day)
+0.00%
52-Week Range
€0.00 - €0.02
All Time High
€0.06
About

Glory Health Industry Limited, an investment holding company, engages in the property development business in the People's Republic of China. The company operates through Property Development, Primary Land Construction and Development Services, Property Investment, and Property Management and Related Services segments. The Property Development segment develops and sells commercial and residential… Read more